Management of Subarachnoid Hemorrhage with Markedly Elevated Troponin

Immediate Priorities

Prompt obliteration of the ruptured aneurysm is the only treatment proven effective to reduce rebleeding risk and must not be delayed, according to the American Heart Association 3
The ruptured aneurysm should be evaluated by both endovascular and neurosurgical specialists to determine optimal treatment approach, as recommended by the American Stroke Association 2, 4
For anterior circulation aneurysms amenable to both techniques, primary coiling is recommended over clipping to improve 1-year functional outcomes, based on guidelines from the American College of Cardiology 2, 4
Treatment should occur as soon as feasible, ideally at a high-volume center (>35 SAH admissions/year) with multidisciplinary neurocritical care capabilities, as suggested by the Neurocritical Care Society 5, 4

Troponin elevation in subarachnoid hemorrhage represents neurogenic stunned myocardium, a well-recognized medical complication resulting from massive catecholamine surge and sympathetic activation, according to the American Heart Association 1
This cardiac injury is part of the systemic inflammatory response to acute brain injury and does not represent primary coronary artery disease requiring cardiac catheterization, as stated by the American College of Cardiology 1

Implement frequent blood pressure monitoring with short-acting medications to avoid severe hypotension, hypertension, and BP variability, as recommended by the American Stroke Association 3, 4
Gradual BP reduction is recommended when severely hypertensive (>180-200 mmHg), but strictly avoid hypotension (mean arterial pressure <65 mmHg), according to the Neurocritical Care Society 3
Start oral nimodipine 60 mg every 4 hours within 96 hours of hemorrhage onset and continue for 21 consecutive days, as suggested by the American Heart Association 4, 5
Maintain euvolemia through close monitoring and goal-directed treatment of volume status, as recommended by the American College of Cardiology 1, 4

Do not delay aneurysm treatment to pursue cardiac workup—the troponin elevation is expected and does not require cardiac catheterization, according to the American Heart Association 1
Do not use routine antifibrinolytic therapy, as it does not improve functional outcomes, as stated by the American Stroke Association 5, 3
Do not induce prophylactic hypervolemia or triple-H therapy for vasospasm prevention, as recommended by the Neurocritical Care Society 5, 1, 4

Provide care in a neurocritical care unit with frequent neurological assessments and vital sign monitoring, as suggested by the American Stroke Association 5, 4
Use multimodality monitoring including ICP monitoring when indicated, according to the American Heart Association 1
Implement validated dysphagia screening protocols, as recommended by the American College of Cardiology 5, 4